Terminated NA INTERVENTIONAL 2-arm NCT06069453

Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.

Intravesical Hyaluronic Acid Sodium Salt and Hydeal-D for Relief of Storage Lower Urinary Tract Symptoms (LUTS) After Trans-urethral Resection of Bladder Tumor (TURBT) for Non-muscle Invasive Bladder Cancer (NMIBC). Monocentric, Randomized, Controlled Investigation.

Sponsor: Fidia Farmaceutici s.p.a.

Conditions Non-muscle Invasive Bladder Cancer (NMIBC)

Interventions Hyaluronic Acid (HA) sodium salt and Hydeal-D

Updated 3 times since 2023 Last updated: Sep 29, 2023 Started: Aug 19, 2020 Primary completion: Dec 22, 2022 Completion: Dec 22, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other terminated trials from Fidia Farmaceutici s.p.a.

More terminations from Fidia Farmaceutici s.p.a.

This NA trial investigates Non-muscle Invasive Bladder Cancer (NMIBC) and is currently terminated or withdrawn. Fidia Farmaceutici s.p.a. leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Nov 2023 — Jul 2024 [monthly]

Terminated NA

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fidia Farmaceutici s.p.a.

Data source: Fidia Farmaceutici s.p.a.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rozzano, Italy